| 000 | 01551nam a22003014i 4500 | ||
|---|---|---|---|
| 001 | 8968 | ||
| 999 |
_c8968 _d8968 |
||
| 003 | ES-VaUE | ||
| 005 | 20201214204118.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr cn |||mnn|| | ||
| 008 | 201214s2020 ||||| |||| 00| 0 eng d | ||
| 020 | _a978-3-030-57949-4 | ||
| 040 |
_bspa _cUEV _dES-VaUE |
||
| 050 |
_aRC268.3 _b.C36 2020 EB |
||
| 245 |
_aCancer Immunology : _bBench to Bedside Immunotherapy of Cancers _cNima Rezaei (editor) |
||
| 260 |
_aCham _bSpringer _c2020 |
||
| 300 | _a1 recurso en línea | ||
| 336 |
_2rdacontent _aTexto (visual) _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 520 | _aThis translational, clinically oriented book describes in detail novel approaches to cancer immunotherapy, current strategies to target tumor immunosuppression, and prognostic biomarkers for personalized cancer treatments. Since the first, very successful edition of the book was published in 2015, the original chapters have been significantly updated and entirely new chapters are included on, for example, cancer immunoprevention, aptamer-mediated cancer gene therapy, haploidentical bone marrow transplantation for pediatric malignancies, and nanoimmunotherapy. | ||
| 650 | 7 |
_2embne _98412 _aHematología |
|
| 650 | 0 |
_9516571 _aOncología |
|
| 700 |
_9516572 _aRezaei, Nima |
||
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/openurl?genre=book&isbn=978-3-030-57949-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia) |
| 942 |
_2lcc _cLE |
||
| 998 | _db | ||